Go Pro

Shore Capital Group's Rating of Creo Medical Group on 5/26/2026

On May 26, 2026, Shore Capital Group updated its outlook on Creo Medical Group (LON:CREO) with the action "Reiterated Rating", keeping a "House Stock" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Shore Capital Group Ltd

DateCompanyAction
7/1/2026
JD Sports Fashion Plc stock logo
JD
JD Sports Fashion
Reiterated Rating
7/1/2026
Debenhams Capital PLC stock logo
DEBS
Debenhams Capital
Reiterated Rating
7/1/2026
Neo Energy Metals Plc stock logo
NEO
Neo Energy Metals
Reiterated Rating
7/1/2026
Supreme Plc stock logo
SUP
Supreme
Reiterated Rating
6/30/2026
Macfarlane Group PLC stock logo
MACF
Macfarlane Group
Reiterated Rating
6/30/2026
J Sainsbury plc stock logo
SBRY
J Sainsbury
Reiterated Rating
More Ratings From Shore Capital Group Ltd